At IDT Biologika, we are an international leader in the field of biotechnology, a key global technology for the 21st century. Our 95-year tradition of manufacturing vaccines and pharmaceuticals motivates and obligates us to continue our work in improving the health of humans and animals, now and going forward. Today, our company ranks among the top echelon of innovative high-tech life science companies, delivering a consistent level of quality in the standardized production of biopharmaceuticals. We have achieved this position through our commitment to employing highly qualified staff, using state-of-the-art production technologies, and strongly investing in research and development.
Award-winning innovation and quality — IDT focuses on contract manufacturing and animal health. IDT Biologika has received international accolades for the development and manufacturing of new vaccines, as well as its own trail-blazing products in animal health.
Divestment of animal health business unit enables focus on global growth market more info
Ceva Santé Animale and IDT Biologika GmbH announce agreement for Ceva to acquire the IDT animal health business, expanding its global vaccine portfolio and boosting swine innovation more info
IDT Biologika Receives Six 2019 CMO Leadership Awards more info
IDT Biologika Awarded 10-Year NIH Contract to Manufacture Vaccines and Biologics for Infectious Diseases more info
CEPI Awards Contract Worth Up To USD$36 million to Consortium led by IDT to Develop MERS Vaccine more info
RT @iitoLifeScience: IDT Biologika to Divest Animal Health Business Unit to Focus on Production of Human Vaccines & Medicines https://t.co/… more info
RT @CevaSanteAnimal: [Press Release] 📣 Ceva is proud to announce provisional agreement to acquire the animal health business of biopharmac… more info
RT @PharmaMKTnet: IDT Biologika Receives Six 2019 CMO Leadership Awards https://t.co/MQGDkpKWzE more info